[Emphysematous cystitis: Report of 2 cases with different outcomes] | Canada Hyperbarics Skip to main content
Case Report Arch Esp Urol 2015

[Emphysematous cystitis: Report of 2 cases with different outcomes]

Garde H, Useros E, Hernando A, Chávez C, Paños E, Quijano P, et al. — Arch Esp Urol, 2015

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on two cases of a rare and serious bladder infection called emphysematous cystitis.

What They Found

One patient with advanced disease needed emergency surgery to remove their bladder. The second patient, whose disease was caught early, improved with a new treatment combining hyperbaric oxygen therapy and broad-spectrum antibiotics.

What This Means for Canadian Patients

Emphysematous cystitis is a rare but serious bladder infection. This study suggests that for Canadian patients diagnosed early, a combination of hyperbaric oxygen therapy and antibiotics might offer a way to manage the disease without needing major surgery. Early diagnosis is key for better outcomes.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a report on only two cases, these findings cannot be applied to all patients with emphysematous cystitis.

Was this summary helpful?

Study Details

Study Type Case Report
Category Uncategorised
Source Pubmed
PubMed ID 26331400
Year Published 2015
Journal Arch Esp Urol
MeSH Terms Aged; Aged, 80 and over; Cystitis; Emphysema; Female; Humans; Male; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.